4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The use of ingenol mebutate to treat actinic keratosis in standard clinical practice: a prospective phase IV multicenter observational cohort study.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Actinic keratosis (AK) is a chronic, precancerous skin disease. Various treatments options exist, including ingenol mebutate gel. The aim of this study was to compare its effectiveness and tolerability as well as the impact of therapy on patients' quality of life in standard clinical practice.

          Related collections

          Author and article information

          Journal
          Int J Dermatol
          International journal of dermatology
          Wiley
          1365-4632
          0011-9059
          Jun 2020
          : 59
          : 6
          Affiliations
          [1 ] Department of Dermatology, Andreas Sygros Skin Hospital, Athens, Greece.
          [2 ] HeaDS S.A, Athens, Greece.
          Article
          10.1111/ijd.14879
          32301503
          b484ab43-fbed-4d40-ab29-99aa9519b3c8
          History

          Comments

          Comment on this article